Harvest Portfolios Group’s Pfizer PFE Stock Holding History

Harvest Portfolios Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Hold	84,300	–	–	0.03%	173
2026 Q1	$2.37M	Buy	84,300 +11,500	+16%	+$306K	0.04%	173
2025 Q4	$1.81M	Hold	72,800	–	–	0.03%	177
2025 Q3	$1.85M	Buy	72,800 +2,200	+3%	+$54.3K	0.03%	170
2025 Q2	$1.71M	Hold	70,600	–	–	0.04%	160
2025 Q1	$1.79M	Sell	70,600 -300	-0.4%	-$7.85K	0.05%	138
2024 Q4	$1.88M	Hold	70,900	–	–	0.06%	115
2024 Q3	$2.05M	Buy	70,900 +8,200	+13%	+$239K	0.07%	121
2024 Q2	$1.75M	Sell	62,700 -8,100	-11%	-$223K	0.07%	119
2024 Q1	$1.96M	Buy	70,800 +12,000	+20%	+$333K	0.08%	121
2023 Q4	$1.69M	Buy	58,800 +1,700	+3%	+$51.4K	0.07%	123
2023 Q3	$1.89M	Sell	57,100 -1,297,442	-96%	-$45.9M	0.09%	116
2023 Q2	$49.7M	Buy	1,354,542 +185,400	+16%	+$7.22M	2.28%	16
2023 Q1	$47.7M	Buy	1,169,142 +251,784	+27%	+$10.9M	2.34%	17
2022 Q4	$47M	Buy	+917,358	New	+$44M	2.7%	12

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harvest Portfolios Group's PFE Position: Q2 2026 in Review

Harvest Portfolios Group held its Pfizer (PFE) position steady in Q2 2026 at 84,300 shares worth $2.03M. The position accounts for 0.03% of the portfolio, ranked #173.

Harvest Portfolios Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $49.7M in Q2 2023. 2,840 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Harvest Portfolios Group held 84,300 shares of Pfizer worth $2.03M as of Q2 2026.
Harvest Portfolios Group left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.03% of Harvest Portfolios Group's portfolio in Q2 2026, its #173 holding.
Harvest Portfolios Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Harvest Portfolios Group's Pfizer position peaked at $49.7M in Q2 2023.
2,840 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.